Benzinga··Business WireNektar Therapeutics Faces Securities Fraud Lawsuit Over Misleading Trial Claims
Schall Law Firm seeks investors in class action against $NKTR over alleged false statements regarding REZOLVE-AA trial enrollment and integrity.
NKTRsecurities fraudclass action lawsuit